Abstract The FDA-approved fibrate, gemfibrozil, has been used clinically to treat hyperlipidaemia, showing efficacy both in lowering triglycerides and increasing high-density lipoproteins. However, in recent years, the drug has been increasingly investigated for potential clinical use in other diseases. Here, we show for the first time that gemfibrozil promotes healthy lifespan across multiple evolutionarily diverse species.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Pär
Contact Pär, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack